TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 4 | 2 | 3 | 7 | 1 | 28 | -7 | 6 |
| P | %wins | 75 | 75 | 75 | 50 | 75 | 25 | 63 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/24/15 16:44 | 6/23/15 | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wierenga Wendall | CA | D | P | 19 | 3.71 | 0 | 5 | New | 5 | D | -36 | -49 | -38 | -23 | -7 | -2 | 0 | -1 | 0 | 2 | 9 | -3 | -4 | -46 | |
5/12/15 17:12 | 5/11/15 | XNPT | Xenoport Inc | DE | Health | Drug | Pharmaceutical Preparations | Wierenga Wendall | CA | D | P | 28 | 5.63 | 3 | 5 | 21 | 29 | D | -3 | 73 | -20 | -18 | -22 | -22 | -4 | -5 | -2 | 8 | 14 | 9 | 15 | -26 | |
10/24/14 14:41 | 10/22/14 | APRI | Apricus Biosciences, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Wierenga Wendall | CA | D | P | 30 | 1.52 | 0 | 20 | New | 20 | D | -50 | -22 | -31 | -20 | -15 | 9 | 19 | -4 | 3 | 1 | -13 | -22 | 3 | -11 | |
5/27/14 19:43 | 5/27/14 | XNPT | Xenoport Inc | DE | Health | Drug | Pharmaceutical Preparations | Wierenga Wendall | CA | D | P | 40 | 3.99 | 1 | 10 | 71 | 24 | D | -36 | -31 | -26 | -41 | -12 | -1 | 6 | 4 | 6 | -1 | 17 | 21 | 98 | 54 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |